MAP BioPharma acquires Santé Strategy

Press release – Cambridge, UK, October 1st 2019

For immediate release

MAP BioPharma is delighted to announce that Santé Strategy has agreed to become a part of the MAP group of market access companies

Santé Strategy, which provides consultancy services in the Irish Healthcare sector focusing on strategic planning, market access and stakeholder engagement, will be joining the MAP group of market access companies.

Brian Gavin, who formed Santé Strategy following a distinguished career in the BioPharma industry that included senior management roles at GSK, has been appointed Managing Director of MAP BioPharma Ireland.

Announcing the acquisition, MAP BioPharma CEO Christian Hill said “The addition of Brian’s company to MAP supports our vision to be the market leader in accelerating patient access to medicines, devices and diagnostics. Santé Strategy has helped over 40 companies to accelerate access to treatment and we are excited to enhance MAP’s presence in Ireland”.

Brian Gavin commented “We are proud to be joining the MAP group, enabling Santé Strategy to offer its clients a broader base of products and services thereby helping them to achieve their goals more than was previously possible”.

About MAP BioPharma

MAP accelerates patient access to medicines, devices and diagnostics, offering a fully-integrated service covering market access, policy & public affairs and legal consulting. MAP Online is a one-stop portal, which provides comprehensive and up-to-date support across the entire market access process in 15 countries including UK, Ireland, France, Germany, Spain, Italy and the Nordics. Working with MAP BioPharma provides access to an extensive suite of tools and materials that make an otherwise complex process faster and more straightforward.

Tagged with

Published on 1. October 2019 in News Ireland, Press Release